share_log

Altamira Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

SEC announcement ·  Aug 21, 2023 07:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more